Demand for Product Pipeline Review and Analysis Rises in the Global Pharma Industry

Demand for Product Pipeline Review and Analysis Rises in the Global Pharma Industry PR Newswire NEW YORK, LONDON, BERLIN, PARIS, June 28, 2012 NEW YORK, LONDON, BERLIN, PARIS, June 28, 2012 /PRNewswire/ -- Pharma Product Pipeline Review and Competitor analysis reports have seen a steady rise in the Pharma and Healthcare Industry lately. The product pipeline reports are segregated into company based pipeline review and disease based pipeline reports. The company based pipeline review talks about a particular company's research and development focus, information on current developmental pipeline and features on discontinued and dormant projects for all disease and conditions. Whereas the disease based pipeline reports provide information on the therapeutic development, special features on the clinical stage, late-stage and discontinued projects for that particular disease. Scope of the Company based pipeline review and analysis Overview of the company including business description, key information and facts and its locations and subsidiaries. Review of current pipeline of the company's human therapeutic division. Overview of pipeline therapeutics across various therapy areas. Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.